4//SEC Filing
Svoronos Dawn 4
Accession 0000950170-25-083317
CIK 0001582313other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 5:57 PM ET
Size
7.5 KB
Accession
0000950170-25-083317
Insider Transaction Report
Form 4
Graham Dawn
Director
Transactions
- Award
Share Option (Right to Buy)
2025-06-05+17,012→ 17,012 totalExercise: $30.73Exp: 2035-06-04→ Common Shares (17,012 underlying) - Award
Restricted Share Units
2025-06-05+2,645→ 2,645 totalExercise: $0.00→ Common Shares (2,645 underlying)
Footnotes (2)
- [F1]Vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders.
- [F2]Each restricted share unit represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 4, 2026 or (ii) the day before the date of the issuer's 2026 annual meeting of shareholders.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0001574579
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 5:57 PM ET
- Size
- 7.5 KB